The Health and Life Sciences practice serves a range of businesses in the pharmaceutical, health technology, and life sciences industries, as well as companies from other sectors where health policy is a factor in commercial strategy, including social care. We draw on insight from teams across Global Counsel, including technology, trade and sustainability, to provide holistic support for clients, including external challenges and practical advice to engage with the policy process.
Title
HOW WE HELP CLIENTS
Title
Regulatory insight and analysis
Our team monitors and interprets political, policy and regulatory developments as they happen in the UK, Europe, Asia and the Americas. We support clients to track and anticipate regulatory and policy change in preparation, through the legislative process and into implementation at a regional, national and international level. Our monitoring ranges from national government and public sector publications to multilateral and global legislation and developments that affect the sector.
Title
Engaging the policymaking process
We support clients to engage with the policymaking process, including: stakeholder analysis to ensure clients are targeting the right decisionmakers in the right place at the right time; strategic planning to ensure policy and stakeholder engagement is timely and impactful; independent convening through conferences and roundtables; and policy evidence development through in-depth primary and secondary research and advocacy collateral design.
Title
Thought leadership as a route to market
We build on our insight, analysis and government affairs work to provide a unique commercial advisory service. We help our clients build a political brand to elevate conversations with partners in government and the private sector by becoming thought leaders; building a presence with policymakers; and building a reputation with private sector clients and collaborators. Our thought leadership work is equally effective at elevating conversations with like-minded partners in the private sector. We use policy debates as neutral spaces for commercial networking and for building advocacy coalitions.
Title
Assessing political and policy risk on commercial strategy
We support our clients to understand the commercial implications of political risks and opportunities. Using our in-house expertise and GC’s global network of policymakers, we conduct in-depth due diligence research projects to provide crucial commercial advice ahead of investment decisions.
Global Expertise
Our people
The health and life sciences team have demonstrated expertise in public policy and political strategy. They leverage experience from government, politics, think tanks, international organizations, and business to advise clients at all levels, including C-Suites, boards, and government/public affairs and operational teams.
First name
Emma
Eatwell
Emma advises clients where health policy is a factor in commercial planning. She leverages works closely with our technology, trade and sustainability teams to provide holistic support to clients.
First name
Matthew
Swindells
Matthew supports clients in health tech and pharmaceuticals and advises clients in adjacent sectors including social care and medical devices.
First name
Harpreet
Sood
Harpreet advises clients in the health and life sciences industry, bringing extensive hands-on experience as a practicing GP and board member at Health Education England.
First name
Rob
Reid
Rob works with multinational pharmaceutical and life sciences clients to anticipate, understand, and develop policy and advocacy positions on UK, EU, and global political and regulatory change.
First name
Mark
Loughridge
Mark works with corporates and investors in the health and life sciences sector to deliver strategic solutions to policy challenges, helping them navigate health systems, including positioning and market entry.
First name
Florence
Chalker
Florence supports clients in the pharmaceutical sector to understand, develop policy positions on, and engage with anticipated changes to EU and global legislation.
First name
Saskia
Hirsch
Saskia supports clients within the health and life sciences industry across a range of policy issues including pharmaceuticals, public health, supply chains, R&D, and health technology.